288 related articles for article (PubMed ID: 12360492)
1. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.
Canbay A; Higuchi H; Bronk SF; Taniai M; Sebo TJ; Gores GJ
Gastroenterology; 2002 Oct; 123(4):1323-30. PubMed ID: 12360492
[TBL] [Abstract][Full Text] [Related]
2. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas.
Miyoshi H; Rust C; Roberts PJ; Burgart LJ; Gores GJ
Gastroenterology; 1999 Sep; 117(3):669-77. PubMed ID: 10464144
[TBL] [Abstract][Full Text] [Related]
4. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
5. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.
Kahraman A; Barreyro FJ; Bronk SF; Werneburg NW; Mott JL; Akazawa Y; Masuoka HC; Howe CL; Gores GJ
Hepatology; 2008 Apr; 47(4):1317-30. PubMed ID: 18220275
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in mice.
Ogawa A; Tagawa T; Nishimura H; Yajima T; Abe T; Arai T; Taniguchi M; Takeda K; Akira S; Nimura Y; Yoshikai Y
Gut; 2006 Jan; 55(1):105-13. PubMed ID: 16118350
[TBL] [Abstract][Full Text] [Related]
7. α7-nAChR Knockout Mice Decreases Biliary Hyperplasia and Liver Fibrosis in Cholestatic Bile Duct-Ligated Mice.
Ehrlich L; O'Brien A; Hall C; White T; Chen L; Wu N; Venter J; Scrushy M; Mubarak M; Meng F; Dostal D; Wu C; Lairmore TC; Alpini G; Glaser S
Gene Expr; 2018 Aug; 18(3):197-207. PubMed ID: 29580318
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.
Canbay A; Guicciardi ME; Higuchi H; Feldstein A; Bronk SF; Rydzewski R; Taniai M; Gores GJ
J Clin Invest; 2003 Jul; 112(2):152-9. PubMed ID: 12865404
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
[TBL] [Abstract][Full Text] [Related]
10. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
11. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
[TBL] [Abstract][Full Text] [Related]
12. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation.
Gujral JS; Liu J; Farhood A; Jaeschke H
Hepatology; 2004 Oct; 40(4):998-1007. PubMed ID: 15382126
[TBL] [Abstract][Full Text] [Related]
13. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
[TBL] [Abstract][Full Text] [Related]
14. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
[TBL] [Abstract][Full Text] [Related]
16. Reduction of hepatocellular injury after common bile duct ligation using omega-3 fatty acids.
Lee S; Kim S; Le HD; Meisel J; Strijbosch RA; Nose V; Puder M
J Pediatr Surg; 2008 Nov; 43(11):2010-5. PubMed ID: 18970933
[TBL] [Abstract][Full Text] [Related]
17. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
Wang H; Zhang Y; Heuckeroth RO
Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
[TBL] [Abstract][Full Text] [Related]
18. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
[TBL] [Abstract][Full Text] [Related]
19. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.
Moon JO; Welch TP; Gonzalez FJ; Copple BL
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G582-92. PubMed ID: 19136383
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease.
Mitchell C; Mahrouf-Yorgov M; Mayeuf A; Robin MA; Mansouri A; Fromenty B; Gilgenkrantz H
Lab Invest; 2011 Feb; 91(2):273-82. PubMed ID: 20856227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
